NCNA Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:NCNA

NuCana plc

$1.98

0.01+0.51%

At Close 4:00 PM

$1.95

-0.03-1.52%

Pre-Market 06:38 PM

76.4

BESG ScoreESG Rating

profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Price Today

NuCana plc (NCNA) stock surged +0.51%, trading at $1.98 on NASDAQ, up from the previous close of $1.97. The stock opened at $1.97, fluctuating between $1.87 and $2.02 in the recent session.

Stock Snapshot

1.97

Prev. Close

1.97

Open

4.45M

Market Cap

2.25M

Number of Shares

1.872

Day Low

2.0199

Day High

-0.12

P/E Ratio

88.12%

Free Float in %

-17.19

EPS (TTM)

0.28

Book Value

-0.51

Cash Flow per Share

170.96K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Oct 04, 2024	1.97	2.02	1.87	1.98	170.96K
Oct 03, 2024	1.98	2.07	1.92	1.97	130.5K
Oct 02, 2024	2.08	2.08	1.89	2.02	306.92K
Oct 01, 2024	2.22	2.36	2.03	2.07	323.04K
Sep 30, 2024	2.47	2.50	2.25	2.30	463.66K
Sep 27, 2024	2.50	2.89	2.43	2.45	749.2K
Sep 26, 2024	3.62	3.66	2.64	2.75	4.2M
Sep 25, 2024	3.26	3.40	3.00	3.05	2.72M
Sep 24, 2024	3.18	3.42	3.12	3.33	361.24K
Sep 23, 2024	3.16	3.35	3.10	3.23	129.61K
Sep 20, 2024	3.24	3.41	3.09	3.22	272.8K
Sep 19, 2024	3.52	3.63	3.21	3.26	451.1K
Sep 18, 2024	3.89	4.08	3.29	3.44	957.45K
Sep 17, 2024	5.84	5.91	3.53	3.70	3.1M
Sep 16, 2024	6.41	8.25	5.71	6.37	66.83M
Sep 13, 2024	2.44	2.64	2.34	2.54	69.49K
Sep 12, 2024	2.70	2.73	2.48	2.55	170.04K
Sep 11, 2024	2.67	2.93	2.55	2.62	50.81K
Sep 10, 2024	2.76	3.20	2.55	2.85	199.77K
Sep 09, 2024	2.83	3.04	2.66	2.76	40.69K

Contact Details

Edinburgh, EH12 9DT

United Kingdom

Website: https://www.nucana.comContact: 441 313 571111

About Company

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary tract cancer; Phase II clinical trial for the treatment of patients with platinum-resistant ovarian cancer; and Phase III clinical trial for the treatment of patients with pancreatic cancer. The company is also developing NUC-3373, a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil, which is in Phase I clinical trial for the treatment of patients with advanced solid tumors and in a Phase 1b/2 clinical trial for patients with advanced colorectal cancer; and NUC-7738, a nucleoside analog that is in Phase 1/2 clinical trial for the treatment of patients with advanced solid tumors and hematological tumors. It has a research, collaboration, and license agreement with Cardiff University and University College Cardiff Consultants Ltd. for the design, synthesis, characterization, and evaluation of ProTides; and an assignment, license, and collaboration agreement with Cardiff ProTides Ltd. The company was formerly known as NuCana BioMed Limited and changed its name to NuCana plc in August 2017. NuCana plc was incorporated in 1997 and is headquartered in Edinburgh, the United Kingdom.

Frequently Asked Questions

What is the current NuCana plc (NCNA) stock price?

NuCana plc (NASDAQ: NCNA) stock price is $1.98 in the last trading session. During the trading session, NCNA stock reached the peak price of $2.02 while $1.87 was the lowest point it dropped to. The percentage change in NCNA stock occurred in the recent session was 0.51% while the dollar amount for the price change in NCNA stock was $0.01.

NCNA's industry and sector of operation?

The NASDAQ listed NCNA is part of Biotechnology industry that operates in the broader Healthcare sector. NuCana plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NCNA?

Martin Quinn
Company Sec.
Prof. Christopher B. Wood FRCS, M.D., Ph.D.
Chief Medical Officer
Mr. Hugh Stephen Griffith
Founder, Chief Executive Officer & Executive Director
Mr. Donald Munoz
Chief Financial Officer
Mr. David Harrison
Head of Translational Medicine
Ms. Theresa Bruce
Senior Vice President of Clinical Operations
Ms. Elisabeth Oelmann
Senior Vice President of Medical & Clinical Devel.
Dr. Jeffrey D. Bloss F.A.C.O.G., M.D.
Chief Medical Officer

How NCNA did perform over past 52-week?

NCNA's closing price is 5.77% higher than its 52-week low of $1.87 where as its distance from 52-week high of $20.25 is -90.22%.

How many employees does NCNA have?

Number of NCNA employees currently stands at 25.

Link for NCNA official website?

Official Website of NCNA is: https://www.nucana.com

How do I contact NCNA?

NCNA could be contacted at phone 441 313 571111 and can also be accessed through its website. NCNA operates from 3 Lochside Way, Edinburgh, EH12 9DT, United Kingdom.

How many shares of NCNA are traded daily?

NCNA stock volume for the day was 170.96K shares. The average number of NCNA shares traded daily for last 3 months was 1.4M.

What is the market cap of NCNA currently?

The market value of NCNA currently stands at $4.45M with its latest stock price at $1.98 and 2.25M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Stock Price Today

NuCana plc (NCNA) stock surged +0.51%, trading at $1.98 on NASDAQ, up from the previous close of $1.97. The stock opened at $1.97, fluctuating between $1.87 and $2.02 in the recent session.

Stock Snapshot

1.97

Prev. Close

1.97

Open

4.45M

Market Cap

2.25M

Number of Shares

1.872

Day Low

2.0199

Day High

-0.12

P/E Ratio

88.12%

Free Float in %

-17.19

EPS (TTM)

0.28

Book Value

-0.51

Cash Flow per Share

170.96K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Oct 04, 2024	1.97	2.02	1.87	1.98	170.96K
Oct 03, 2024	1.98	2.07	1.92	1.97	130.5K
Oct 02, 2024	2.08	2.08	1.89	2.02	306.92K
Oct 01, 2024	2.22	2.36	2.03	2.07	323.04K
Sep 30, 2024	2.47	2.50	2.25	2.30	463.66K
Sep 27, 2024	2.50	2.89	2.43	2.45	749.2K
Sep 26, 2024	3.62	3.66	2.64	2.75	4.2M
Sep 25, 2024	3.26	3.40	3.00	3.05	2.72M
Sep 24, 2024	3.18	3.42	3.12	3.33	361.24K
Sep 23, 2024	3.16	3.35	3.10	3.23	129.61K
Sep 20, 2024	3.24	3.41	3.09	3.22	272.8K
Sep 19, 2024	3.52	3.63	3.21	3.26	451.1K
Sep 18, 2024	3.89	4.08	3.29	3.44	957.45K
Sep 17, 2024	5.84	5.91	3.53	3.70	3.1M
Sep 16, 2024	6.41	8.25	5.71	6.37	66.83M
Sep 13, 2024	2.44	2.64	2.34	2.54	69.49K
Sep 12, 2024	2.70	2.73	2.48	2.55	170.04K
Sep 11, 2024	2.67	2.93	2.55	2.62	50.81K
Sep 10, 2024	2.76	3.20	2.55	2.85	199.77K
Sep 09, 2024	2.83	3.04	2.66	2.76	40.69K

Contact Details

Edinburgh, EH12 9DT

United Kingdom

Website: https://www.nucana.comContact: 441 313 571111

About Company

Frequently Asked Questions

What is the current NuCana plc (NCNA) stock price?

NCNA's industry and sector of operation?

Who are the executives of NCNA?

How NCNA did perform over past 52-week?

NCNA's closing price is 5.77% higher than its 52-week low of $1.87 where as its distance from 52-week high of $20.25 is -90.22%.

How many employees does NCNA have?

Number of NCNA employees currently stands at 25.

Link for NCNA official website?

Official Website of NCNA is: https://www.nucana.com

How do I contact NCNA?

NCNA could be contacted at phone 441 313 571111 and can also be accessed through its website. NCNA operates from 3 Lochside Way, Edinburgh, EH12 9DT, United Kingdom.

How many shares of NCNA are traded daily?

NCNA stock volume for the day was 170.96K shares. The average number of NCNA shares traded daily for last 3 months was 1.4M.

What is the market cap of NCNA currently?

The market value of NCNA currently stands at $4.45M with its latest stock price at $1.98 and 2.25M of its shares outstanding.

Employees	25
Beta	1.021
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	25
Beta	1.021
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

NCNA Stock Price History and Quote Analysis: Insights for Investors

NuCana plc

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions